fig1

From: The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation

The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation

Figure 1. Assessment of sarcopenia in patients with cirrhosis. Using imagine software analysis (Fujifilm Synapse 3D™), the total cross-sectional muscle area (CSMA, cm²) at level of 3rd lumbar vertebra was calculated. CSMA was then divided per patient’s height to calculate the skeletal muscle index (SMI) (cm²/m²). Sarcopenia was defined by SMI < 50 cm²/m² in male patients and < 39 cm²/m² in female patients, respectively

fig1

Portico

Portico